Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. - Wikidata - awgldk - TriplyDB

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

http://www.wikidata.org/entity/Q36196462

about

Pharmacological interventions for peripheral artery disease Potential therapeutic action of nitrite in sickle cell disease Nitric oxide release: part II. Therapeutic applications.Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor Nitric oxide and hormones in breast cancer: allies or enemies?Nitric oxide/redox-based signalling as a therapeutic target for penile disorders.Synthesis and in vitro anti-leukemic activity of structural analogues of JS-K, an anti-cancer lead compound.The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs.NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy.Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).Gelatin-siloxane nanoparticles to deliver nitric oxide for vascular cell regulation: synthesis, cytocompatibility, and cellular responses.The latest advances in the discovery of nitric oxide hybrid drug compounds.The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline.Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.Impact of novel N-aryl piperamide NO donors on NF-κB translocation in neuroinflammation: rational drug-designing synthesis and biological evaluation.Supplementation of bovine embryo culture medium with L-arginine improves embryo quality via nitric oxide production.

P2860

Q28218976-8BAF30B0-442F-43ED-B928-F5F2BFCF4F5E Q33681568-B7AB499A-B24A-4868-B9E8-21568A64AB44 Q35926097-8161EF06-0EC0-4464-9D09-172274FF7126 Q35994624-54A56784-D15F-4CC5-9322-0EF6A8794F15 Q36430756-C3CCEC00-831F-4DFD-B49E-A2C23B48A5D8 Q36481074-EA27FA84-FAA9-496A-AB5F-DFB0CBD36F11 Q36516264-D6020647-6E7C-44C9-8DB7-22566E375E7B Q36809514-C3A1981D-6CFA-44C7-B56F-785025B1CB52 Q37070223-BC3EFA35-B2ED-4DA4-8322-CBEE32C92BB5 Q37074663-39A7C1CC-FDCF-40C7-A88B-155F052231E6 Q37074670-D182CB47-E0C0-4BA2-A7D4-46F337629CDE Q37166556-0DAC8CA8-8158-4761-83A5-065B3F272444 Q37881801-6E3AD1FB-00FC-4D8F-9B0C-9118484337D9 Q38844542-20E6F540-9BF2-4968-998F-63ECE71990E5 Q38992603-C78683C3-EACA-443F-91CF-653C85FAFDE8 Q39406582-36E534A7-B473-4EE3-B987-6A07F34BBAEA Q41575117-BFF86077-9D14-44A3-A07C-08C24E94915D Q46173433-2CC2C0CC-D5E7-41B1-81BD-08B8F1DD96D7 Q49959079-F6355315-963B-43C3-9CF8-437DCD0960AC Q53441047-33C4C346-725D-40E0-87D7-51ECED2A888E

P2860

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

http://www.wikidata.org/entity/Q36196462

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

@ast

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

@en

type

label

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

@ast

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

@en

prefLabel

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

@ast

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

@en

P1433

Q36196462-04014617-8FB0-4763-842C-96D908E54D32

P1476

Q36196462-47549215-431E-4413-AFDE-74F557C824BE

P2093

Q36196462-5AD2134E-8EFC-4DAE-9D0E-373C27FE8007

Q36196462-76063D7E-10E6-43BE-9DF3-C8E6C4F309D8

Q36196462-EC734D21-0768-4A89-AB38-3975D1E6E153

Q36196462-FA8CBA7E-9AA7-4384-B90B-807FF1E25B4D

P2860

Q36196462-019A9920-425C-4B90-89DA-8A0D30E394B8

Q36196462-037EEC3F-098B-4DEB-9438-6CE9DACAF7FA

Q36196462-1070EF93-8221-4B71-B220-BD484C87097B

Q36196462-18D95CC8-29B1-43E7-B528-1AB9FF56005F

Q36196462-234FFAEB-65A7-4167-B0FB-B1635FD8F420

Q36196462-2B7D6B4E-3118-4F8D-B8DA-927CB23F9B1D

Q36196462-2F94C657-9779-432C-809A-E2BA39FC1519

Q36196462-317E8995-2C0E-4D35-AE06-1C4ABCE48E54

Q36196462-31B8A749-B637-4D65-80A5-26BF7B363842

Q36196462-3256A550-4733-456E-94FE-01D570B5F180

P304

Q36196462-3FDF66B6-A58E-4830-A51E-041C47608397

P31

Q36196462-D0BD4B20-5EF9-483B-A5E5-79EC28867D09

P356

Q36196462-CD97D0EE-2DE6-45D5-8EE2-288C975069FD

P407

Q36196462-5951F171-5CF0-4564-8627-806279071167

P433

Q36196462-D9029418-0CBB-4906-81F5-08E17AC333A6

P478

Q36196462-88C06F6C-5D5F-4B86-B8E6-D1EC24534865

P577

Q36196462-77A4CF31-9A9D-4F1C-A379-0EAD0E935F00

P698

Q36196462-C2354784-0602-4329-98CD-EB1C2A13F3AA

P356

13543784.14.7.835

P1433

Expert Opinion on Investigational Drugs

P1476

Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.

@en

P2093

Bruno Giardina

http://www.w3.org/2001/XMLSchema#string

Giuseppe E Martorana

http://www.w3.org/2001/XMLSchema#string

Patrizia Bottoni

http://www.w3.org/2001/XMLSchema#string

Roberto Scatena

http://www.w3.org/2001/XMLSchema#string

P2860

The L-arginine-nitric oxide pathway

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans

In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines

Free radicals in the physiological control of cell function

Nitric oxide-releasing aspirin inhibits vasoconstriction in perfused tail artery of normotensive and spontaneously hypertensive rats

Nitric oxide-releasing non steroidal anti-inflammatory drugs: a new generation of anti-tumoral molecules

Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaB

Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3

Potential cardioprotective actions of no-releasing aspirin

Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin

P304

835-846

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.14.7.835

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16022573

http://www.w3.org/2001/XMLSchema#string